{"id":"doi:10.1016/j.cell.2017.10.025","kind":"article","title":"In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation","authors":["Hsin‐Kai Liao","Fumiyuki Hatanaka","Toshikazu Araoka","Pradeep Reddy","Min-Zu Wu","Yinghui Sui","Takayoshi Yamauchi","Masahiro Sakurai","David D. O’Keefe","Estrella Núñez‐Delicado","Pedro Guillén","Josep Maria Campistol","Cheng-Jang Wu","Li‐Fan Lu","Concepción Rodrı́guez Esteban","Juan Carlos Izpisúa Belmonte"],"author_count":16,"year":2017,"published":"2017-12-01","venue":"Cell","cited_by":451,"doi":"10.1016/j.cell.2017.10.025","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/j.cell.2017.10.025","archive_url":"https://space-kitty.com/papers/doi:10.1016/j.cell.2017.10.025","updated":null,"pmid":"29224783","pmcid":null,"openalex_id":"W2772697618","pdf_url":"http://www.cell.com/article/S0092867417312473/pdf","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["CRISPR and Genetic Engineering"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"gene-editing-therapies","name":"CRISPR & Gene-Editing Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}